AzTrials
AzTrials

Being LiterateNCT06979960

The Effect of Face-to-Face and Online Training on Cancer Screening on Women's Knowledge, Attıtude and Shyness

A study testing cancer screening education in people with Being Literate and Not Having Any Cognitive, Visual or Orthopedic Disabilities, run by Inonu University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cancer is a large group of diseases that occur due to abnormal cell proliferation in almost all organs of the body. Cancer is the second leading cause of death in the world after cardiovascular diseases. The fact that cancer is a preventable disease reveals the importance of cancer screenings. Read more about this study

Who is it for?
Ages 50 to 65 years, women onlyHealthy volunteers can take part
What is being tested?
cancer screening education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2024to 31 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 65 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Being between the ages of 50-65
  • Being literate
  • Having a smart mobile phone
  • No cognitive, visual or orthopedic disabilities

Who cannot join

  • Not answering questions completely. Being diagnosed with a psychiatric disease.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Inönü University

    Malatya, Malatya, 44000

Other trials in Turkey (Türkiye)

About this study

Cancer is a large group of diseases that occur due to abnormal cell proliferation in almost all organs of the body. Cancer is the second leading cause of death in the world after cardiovascular diseases. The fact that cancer is a preventable disease reveals the importance of cancer screenings. Cancer screening aims to detect it in the early stages when the chance of treatment is high. Screening programs for breast cancer, cervical cancer and colorectal cancer are recommended by WHO. In order for these screening programs to achieve their goals, people within the scope of screening must participate in screening. However, there are many factors involved in participating in these screening programs. Even though health professionals direct people to screening programs, at this point people's knowledge, attitude and shyness levels affect their participation in screening programs. The research is planned to be experimentally pre-test-post-test, and the data will be collected before and after the training to be given face-to-face and online by the researcher. The results obtained as a result of the study will be taken into consideration by midwives in terms of the effect of the education given on cancer screenings on women's knowledge, attitude and shyness levels.

Being tested
cancer screening education
Keywords
cancer screenings, midwife, knowledge, attitude, shyness, woman, online education
Medical subject headings
Behavior, Shyness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cancer screening educationBehavioural

    It will be carried out to examine the effect of the educational intervention given using the cancer screening training booklet on women's knowledge, attitude and shyness levels.

Study groups in NCT06979960
Study groupRoleWhat they receive
training groupExperimentalFirst interview: The women in the experimental group who applied to the Ketem unit were met and informed about the study. After the consent of the women who agreed to participate in the research was obtained; Personal information form and scales were applied. Then the first part of the training session was held. For the second phase of the training session, the appointment place, day and time were determined one week later. Participants were given a training booklet. Second meeting: In the second meeting, 1 week after the first training, the second part of the training, namely breast cancer screening program, cervical cancer screening program and colorectal cancer screening program, was held. Third interview: A reminder training was held over the phone 1 week after the second training. Fourth interview: Post-test data were obtained by telephone by the researcher 2 weeks after the reminder training was implemented.
Receives: Behavioral: cancer screening education
control groupNo interventionThe women in the control group who applied to the Ketem unit were introduced to the first interview and their written consent was obtained, and then the personal information form and scales were applied. After the personal information form and scales were applied again 4 weeks after the first interview, the post-test data were obtained. After the post-test data were obtained, the women in the control group, who were not subjected to any intervention, were given an educational booklet in line with the "Equality" principle.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knowledge Scale for Cancer Screening

    This scale, which consists of 25 items and 3 sub-dimensions, has no special names for its sub-dimensions. The scale; The items in the 1st sub-dimension are items 8, 17-23, 25, 28, totaling 10 items, The items in the 2nd sub-dimension are items 4, 5, 7, 10, 12,13, 15, 16, 27, totaling 9 items,The items in the 3rd sub-dimension are items 1-3, 9, 11, 24, totaling 6 items. This scale, which is answered in a range from 1 to 3 as ''1: True, 2: False, 3: I don't know'', is a three-point rating type. When calculating the scale score, the ''True'' answers are given 1 point, and the ''False'' and ''I don't know'' answers are given 0 points. The lowest possible score for this scale is 0, and the highest possible score is 25. Items 2, 11, and 24 of this scale, which has three negatively connoted items, should be reverse coded. The order of use of the items in the scale is not important and researchers can use them in a mixed order.

    Measured: first day encountered

  2. Attitude Scale Towards Cancer Screening

    The Attitude Scale Towards Cancer Screenings was developed by Yıldırım Öztürk and his colleagues in 2020, and its Turkish validity and reliability study was conducted. This scale, consisting of 24 items and a single dimension, is a five-point Likert-type scale. The items of the scale, which are answered in the range of 1 to 5, are as follows: 1: I completely disagree, 2: I somewhat disagree, 3: I neither agree nor disagree, 4: I somewhat agree, 5: I completely agree. This scale is suitable for evaluating individuals whose age range is 30-70, whose education level is at least literate, and who do not have cognitive, visual or orthopedic disabilities that would prevent them from answering the questions on the scale. There is no specific cut-off point for this scale, where the lowest score is 24 and the highest is 120.Scores close to 24 on the scale indicate that individuals have a negative attitude towards cancer screening.

    Measured: first day encountered

  3. Shyness scale

    This scale, which is a 5-point Likert-type scale ranging from 1 to 5, has 20 items that include expressions regarding feelings and behaviors that can be used to determine how shy individuals perceive themselves as. Individuals are asked to mark one of the following answers opposite the statements on the scale: "Not at all suitable for me," "Not suitable," "Undecided," or "Very suitable for me." As a result, the calculation is made by giving 1 (One) point to the item "Not at all suitable for me," 2 (Two) points to the item "Not suitable for me," 3 (Three) points to the item "Undecided," 4 (Four) points to the item "Suitable for me," and 5 (Five) points to the item "Very suitable for me." The lowest score that can be obtained from the scale is 20, while the highest score is 100. A high score on the scale indicates that the individual perceives himself as "shy."

    Measured: first day encountered

Secondary outcomes (3)
  1. Attitude Scale Towards Cancer Screening

    The Attitude Scale Towards Cancer Screenings was developed by Yıldırım Öztürk and his colleagues in 2020, and its Turkish validity and reliability study was conducted. This scale, consisting of 24 items and a single dimension, is a five-point Likert-type scale. The items of the scale, which are answered in the range of 1 to 5, are as follows: 1: I completely disagree, 2: I somewhat disagree, 3: I neither agree nor disagree, 4: I somewhat agree, 5: I completely agree. This scale is suitable for evaluating individuals whose age range is 30-70, whose education level is at least literate, and who do not have cognitive, visual or orthopedic disabilities that would prevent them from answering the questions on the scale. There is no specific cut-off point for this scale, where the lowest score is 24 and the highest is 120. Scores close to 24 on the scale indicate that individuals have a negative attitude towards cancer screening.

    Measured: up to 4th week after registration

  2. Knowledge Scale for Cancer Screening

    This scale, which consists of 25 items and 3 sub-dimensions, has no special names for its sub-dimensions. The scale; The items in the 1st sub-dimension are items 8, 17-23, 25, 28, totaling 10 items, The items in the 2nd sub-dimension are items 4, 5, 7, 10, 12,13, 15, 16, 27, totaling 9 items,The items in the 3rd sub-dimension are items 1-3, 9, 11, 24, totaling 6 items. This scale, which is answered in a range from 1 to 3 as ''1: True, 2: False, 3: I don't know'', is a three-point rating type. When calculating the scale score, the ''True'' answers are given 1 point, and the ''False'' and ''I don't know'' answers are given 0 points. The lowest possible score for this scale is 0, and the highest possible score is 25. Items 2, 11, and 24 of this scale, which has three negatively connoted items, should be reverse coded. The order of use of the items in the scale is not important and researchers can use them in a mixed order.

    Measured: up to 4th week after registration

  3. Shyness scale

    This scale, which is a 5-point Likert-type scale ranging from 1 to 5, has 20 items that include expressions regarding feelings and behaviors that can be used to determine how shy individuals perceive themselves as. Individuals are asked to mark one of the following answers opposite the statements on the scale: "Not at all suitable for me," "Not suitable," "Undecided," or "Very suitable for me." As a result, the calculation is made by giving 1 (One) point to the item "Not at all suitable for me," 2 (Two) points to the item "Not suitable for me," 3 (Three) points to the item "Undecided," 4 (Four) points to the item "Suitable for me," and 5 (Five) points to the item "Very suitable for me." The lowest score that can be obtained from the scale is 20, while the highest score is 100. A high score on the scale indicates that the individual perceives himself as "shy."

    Measured: up to 4th week after registration

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2025
  2. Study start1 Sep 2024
  3. Primary completion31 Dec 2024
  4. Study completion31 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Experimental Group; First interview: The women in the experimental group who applied to the Ketem unit were met and informed about the study. After the consent of the women who agreed to participate in the research was obtained; Personal information form and scales were applied. Then the first part of the training session was held. For the second phase of the training session, the appointment place, day and time were determined one week later. Participants were given a training booklet. Second meeting: In the second meeting, 1 week after the first training, the second part of the training, namely breast cancer screening program, cervical cancer screening program and colorectal cancer screening program, was held.Third interview: A reminder training was held over the phone 1 weekafter the second training.Fourth interview: Post-test data were obtained by telephone by the researcher 2 weeks after the reminder training was implemented.Control Group;no action taken
Masking
None (open label)
Enrolment
68 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06979960
Sponsor's protocol ID
2024/5731
Status last verified
Feb 2025
First submitted
2 May 2025
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all IPD underlying results in a publication

Questions about this trial

What is this clinical trial studying?

A study testing cancer screening education in people with Being Literate and Not Having Any Cognitive, Visual or Orthopedic Disabilities, run by Inonu University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knowledge Scale for Cancer Screening (time frame: first day encountered). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in